Advertisements


We are Sorry, This Page doesn't Exist


Roche Boosts Diagnostics Portfolio With $1.8B Bet On COVID-19 Test Manufacturer GenMark

Swiss drug giant Roche Holding AG (OTC: RHHBY) announced a big-ticket acquisition that would boost its presence in the diagnostics market, setting the tempo for a merger Monday. read more.....»»

Category: blogSource: benzingaMar 15th, 2021

New data on Eli Lilly"s experimental Alzheimer"s drug backs a hotly debated scientific theory, but shows mixed benefits for patients

Eli Lilly's treatment reduced a harmful substance in the brains of patients with Alzheimer's disease and slowed their rate of cognitive decline. Patients sit inside the Alzheimer's Foundation in Mexico City Thomson Reuters Eli Lilly's.....»»

Category: topSource: businessinsiderMar 13th, 2021

: Novavax stock rallies on COVID-19 vaccine study results

Novavax Inc. NVAX shares rallied in the extended session Thursday after the biotech drug maker said studies show its COVID-19 vaccine is highly effective. Novavax shares surged 17% after hours,.....»»

Category: topSource: marketwatchMar 11th, 2021

Merck to buy drug developer Pandion Therapeutics for $1.85B

Pandion’s lead drug candidate, PT101, last month met its main goals of safety and tolerability in an early-stage trial in patients with autoimmune diseases......»»

Category: topSource: foxnewsFeb 25th, 2021

GSK to refocus study of experimental COVID-19 antibody treatment on patients 70 and older

Shares of GlaxoSmithKline were down 0.2% in trading on Thursday after the drug maker said its experimental monoclonal antibody treatment did not meet the primary endpoint in a mid-stage trial evaluating its use in hospitalized COVID-19 patients of all a.....»»

Category: topSource: marketwatchFeb 25th, 2021

Number of medical marijuana patients reaches new high

There are 100,000 certified medical marijuana patients in Massachusetts, the highest number of patients using medical marijuana since the drug was legalized for medical purposes in 2012.  The number of patients using medical marijuana has grow.....»»

Category: topSource: bizjournalsFeb 13th, 2021

Roche arthritis drug reduced Covid deaths in study, Reuters reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2021

Fecal transplants, made up of poop and microbes, are being touted as a promising new treatment for skin cancer patients

A new study suggests that transplanting fecal matter into the guts of melanoma patients could help them respond better to immunotherapy. Fecal transplants, which are made up of poop an.....»»

Category: topSource: businessinsiderFeb 6th, 2021

PhaseBio patients completed Phase 1b/2a study of PB1046 with no drug-related SEs

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 27th, 2021

Durham drugmaker ends Covid-19 program despite millions in federal funding

A Triangle company that had been awarded tens of millions worth of federal contracts to study its drug's potential for treating Covid-19 patients says it's ending those efforts......»»

Category: topSource: bizjournalsJan 2nd, 2021

Why These 4 Health Care Stocks Are Moving Today

Osmotica Pharmaceuticals (NASDAQ: OSMT) shares were trading higher Monday in anticipation of a ruling by the FDA on the company's New Drug Application for Arbaclofen ER in patients with multiple sclerosis. read more.....»»

Category: blogSource: benzingaDec 28th, 2020

There"s a clear way Biden can immediately take on the pharmaceutical industry and bring down drug prices for all Americans

A new economic analysis shows how anti-competitive industry practices keep drug prices high and hurt patients Hiraman/Getty Images Rebates offered by drug makers incentivize insurance companies to cover some drugs over ot.....»»

Category: personnelSource: nytDec 27th, 2020

: Penumbra stock falls on recall of blood-clot-removing catheter

Penumbra Inc. PEN shares fell in the extended session Tuesday after the medical device maker recalled a type of catheter used for removing blood clots in stroke patients that could cause injury or death. Penumbra shares fell.....»»

Category: topSource: marketwatchDec 17th, 2020

U.S. regulator is reviewing Abbott"s fast COVID test after studies raise accuracy concerns

The U.S. Food and Drug Administration said on Thursday that Abbott Laboratories’ speedy coronavirus test, which can deliver results within minutes and is used at the White House, could potentially be inaccurate but can still be used to test patients......»»

Category: topSource: reutersMay 14th, 2020

GW Pharmaceuticals sells more of CBD-derived epilepsy drug than expected, stock rises

GW Pharmaceuticals PLC shares rose 2.6% in the extended session Monday after the U.K.-based company sold much more of its cannabis derived epilepsy d.....»»

Category: topSource: marketwatchMay 11th, 2020

A new study finds that people who are dying from coronavirus potentially lose at least 10 years of their lives

create jobs 51/Shutterstock A recent study conducted by the University of Glasgow's researchers found that COVID-19 patients might have lasting health impacts. In fact, an average male can lose.....»»

Category: topSource: businessinsiderMay 11th, 2020

Raleigh pharma to study coronavirus treatment on patients in U.S.

A Triangle drugmaker that's seen positive results with its Covid-19 treatment internationally can now start treating patients in the U.S. Raleigh's RedHill Biopharma (Nasdaq: RDHL) has received approval from the U.S. Food and Drug Administration .....»»

Category: topSource: bizjournalsMay 10th, 2020

Government to test remdesivir with Lilly drug in COVID-19 patients

The National I.....»»

Category: topSource: marketwatchMay 8th, 2020

The same number of people could die from ‘deaths of despair’ as have already died in the U.S. from coronavirus, new study finds

‘More Americans could lose their lives to deaths of despair, deaths due to drug, alcohol, and suicide, if we do not do something immediately.’.....»»

Category: topSource: marketwatchMay 8th, 2020

Hospitals are stuck waiting for supplies of a promising coronavirus treatment to arrive, days after health authorities OK"d its emergency use

Associated Press A promising coronavirus treatment called remdesivir was approved last week for emergency use in the US. Now, some hospitals are having a hard time getting the drug for their patients. The US government is deciding which hospitals will .....»»

Category: topSource: businessinsiderMay 6th, 2020